Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-26 @ 12:34 AM
NCT ID:
NCT05856760
Pre Assignment Details:
93 participants were screened; 45 participants were screen failures.
* 29 participants did not meet the inclusion criteria of UA/C ≥0.3 g/g
* 7 participants did not meet the inclusion criteria of being on a stable dose of ACEI and/or ARB
* 5 participants did not meet the inclusion criteria of being on a stable dose of an SGLT2 inhibitor
* 4 participants were excluded for other reasons
Recruitment Details:
Forty-eight participants were enrolled in the study and all 48 (100%) received at least 1 dose of sparsentan.
Sparsentan was prematurely discontinued in 9 participants (19%).
Forty-one participants (85%) completed the study, and 7 participants (15%) discontinued the study. The most common reasons for discontinuation from the study were withdrawal by participant (3 participants \[6%\]) and AEs (2 participants \[4%\]).
Study:
NCT05856760
Study Brief:
Results Section:
NCT05856760